BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2000
View Archived Issues
Roche/deCODE Genetics alliance identifies genetic risk factor for PAOD
Read More
NIH-funded research leads to identification of gene related to autism
Read More
Genzyme General licenses small molecules with potential in lysosomal storage disease therapy
Read More
Xyrem NDA accepted for filing
Read More
Belgian group maintains focus on discovering new TxA2 inhibitors related to torasemide
Read More
Novel SERM devoid of uterotrophic effects presented at Breast Cancer Symposium
Read More
NXY-059 effective in various animal models of stroke and well tolerated in acute stroke patients
Read More
Novel series of antiproliferative compounds patented by Schering
Read More
Microtubule-stabilizing antitumor agents in the Schering pipeline
Read More
NeuroSearch describes new nAChR modulators and their use
Read More
D-Mannitol derivatives useful as anti-HIV agents designed at Pharmacor
Read More
Synthesis and biological activity of Pfizer's new PDE4 inhibitors
Read More
Millennium identifies novel ACE-2 inhibitors for use in cardiovascular disorders
Read More
Imidazoline alpha1A-adrenoceptor agonists especially useful in Rx of urinary incontinence
Read More
Piperidine and piperazine derivatives useful as CCR5 antagonists
Read More
Coulter/Corixa merger update reported
Read More
Final analysis of phase I results for BrevaRex presented to American Society of Hematology
Read More
Synthetic camptothecin derivative shows potential in AML and other hematological malignancies
Read More
Tezacitabine, an antimetabolite nucleoside analogue, assessed in hematological malignancies
Read More
Copaxone launched in the U.K.
Read More
Data presented at AHS meeting support further development of G-3139 in combination regimens
Read More
Mid-November launch in Japan for Allegra
Read More
NeoPharm commences phase I/II trial of SS1(dsFv)-PE38
Read More
Zanamivir as an effective option for preventing household transmission of the flu
Read More
Epimmune licenses Valentis technology for vaccine development
Read More
Atrix completes phase III study of 1-month Leuprogel formulation in advanced prostate cancer
Read More
RUTH trial expanded to include invasive breast cancer prevention as main objective
Read More